The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
C Guo, L Kong, L ** areas in the field of oncology. Many
immunological treatment strategies for refractory tumors have been approved and marketed …
immunological treatment strategies for refractory tumors have been approved and marketed …
Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors
J Huang, C Gong, A Zhou - Therapeutic Advances in …, 2023 - journals.sagepub.com
Although immune checkpoint inhibitors (ICIs) have greatly improved the prognosis of some
cancer patients, the majority still fail to respond adequately, and the available biomarkers …
cancer patients, the majority still fail to respond adequately, and the available biomarkers …
[HTML][HTML] Review–The impact of pharmacogenetics on the outcome of immune checkpoint inhibitors
K de Joode, N Heersche, EA Basak, S Bins… - Cancer Treatment …, 2024 - Elsevier
The development of immune checkpoint inhibitors (ICIs) has a tremendous effect on the
treatment options for multiple types of cancer. Nonetheless, there is a large interpatient …
treatment options for multiple types of cancer. Nonetheless, there is a large interpatient …
The role of microbiota in nasopharyngeal cancer: Where do we stand?
Nasopharyngeal carcinoma (NPC) is a common head and neck cancer with a poor
prognosis. One of the crucial challenges regarding NPC is its pathogenesis. Recent findings …
prognosis. One of the crucial challenges regarding NPC is its pathogenesis. Recent findings …
The association between caffeine intake and the colonic mucosa-associated gut microbiota in humans—A preliminary investigation
We examined the association between caffeine and coffee intake and the community
composition and structure of colonic microbiota. A total of 34 polyp-free adults donated 97 …
composition and structure of colonic microbiota. A total of 34 polyp-free adults donated 97 …
[HTML][HTML] Interconnected influences of tumour and host microbiota on treatment response and side effects in nasopharyngeal cancer
ESY Lim, Y Ong, Y Chou, CK Then - Critical Reviews in Oncology …, 2024 - Elsevier
This study elucidates the intricate relationship between nasopharyngeal carcinoma (NPC), a
significant malignancy predominant in Asia with notable global incidence and mortality …
significant malignancy predominant in Asia with notable global incidence and mortality …
Biomarkers predicting clinical outcomes in nasopharyngeal cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis
X Qian, H Chen, Y Tao - Frontiers in Immunology, 2023 - frontiersin.org
Background Optimal biomarkers to select patients who will benefit most from immunotherapy
remain lacking in nasopharyngeal cancer (NPC). This systematic review and meta-analysis …
remain lacking in nasopharyngeal cancer (NPC). This systematic review and meta-analysis …
Gut Microbiota–Related Biomarkers in Immuno-Oncology
Carcinogenesis is associated with the emergence of protracted intestinal dysbiosis and
metabolic changes. Increasing evidence shows that gut microbiota–related biomarkers and …
metabolic changes. Increasing evidence shows that gut microbiota–related biomarkers and …
Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor
Background We aimed to establish a prognostic model to identify suitable candidates for
chemotherapy combination PD-1 inhibitor in metastatic nasopharyngeal carcinoma (NPC) …
chemotherapy combination PD-1 inhibitor in metastatic nasopharyngeal carcinoma (NPC) …
[PERNYATAAN][C] **aoyan Qian1, Haizhu Chen2, 3 and Yunxia Tao4
E Elkord, X Wang, G Lai, Y Tao - 2023 - europepmc.org
Background: Optimal biomarkers to select patients who will benefit most from
immunotherapy remain lacking in nasopharyngeal cancer (NPC). This systematic review …
immunotherapy remain lacking in nasopharyngeal cancer (NPC). This systematic review …